Robuta

https://www.newswire.com/news/pop-biotechnologies-snap-vaccine-platform-enters-large-scale-phase-iii-21828601 POP Biotechnologies' SNAP Vaccine Platform Enters Large-Scale Phase III Clinical Trials for... phase iii clinical trials